Brinton Pharma gets nod for selling covid-19 tablet2 min read 24 Jul 2020, 05:39 AM IST
Company to market favipiravir under the brand name Faviton, priced at ₹59 a pop
Favipiravir is given orally and thus is more convenient than medicines given through veins
NEW DELHI : Brinton Pharmaceuticals has got the approval of the Drugs Controller General of India (DCGI) for marketing favipiravir under the brand name Faviton for the management of mild to moderate covid-19 patients, the company said on Thursday.
Select your Category